Cannara Biotech, Inc.

  • Market Cap: Small Cap
  • Industry: Other Agricultural Products
  • ISIN: CA13765U2002
CAD
1.67
-0.03 (-1.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Cannara Biotech, Inc. stock-summary
stock-summary
Cannara Biotech, Inc.
Other Agricultural Products
Cannara Biotech Inc. is a Canada-based vertically integrated cannabis company. The Company’s segments include indoor cannabis operations and electronic commerce retail. The indoor cannabis segment's operations include cultivation, processing and sale of dried cannabis and cannabis derivatives for the Quebec and Canadian market. The Company also operates as an electronic commerce retailer of United States hemp-based cannabidiol (CBD) products for the United States market. Its subsidiaries include Cannara Biotech (Quebec) Inc. and ShopCBD.com Inc.
Company Coordinates stock-summary
Company Details
Suite 2050 - 1055 West Georgia Street, Royal Centre, P.O. Box 11121, VANCOUVER BC : V6E 3P3
stock-summary
Tel: 1 514 9139136
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Zohar Krivorot
President, Chief Executive Officer, Director
Mr. Besar Xhelili
Director
Mr. Thomas Faifull
Independent Director
Ms. Amy Satov
Independent Director
Mr. Derek Stern
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
27 Million
(Quarterly Results - May 2025)
Net Profit:
4 Million
stock-summary
Industry

Other Agricultural Products

stock-summary
Market cap

CAD 156 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.33

stock-summary
Return on Equity

-10.12%

stock-summary
Price to Book

1.58